What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
19/5 19:26
Key PointsSaturn V sold 1,504,880 shares of Ocular Therapeutix in the first quarter; the estimated transaction value was $14.34 million....
|
|
|
19/5 19:26
Key PointsSaturn V sold 1,504,880 shares of Ocular Therapeutix in the first quarter; the estimated transaction value was $14.34 million....